Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance

The study aims to use cardiac MRI scans and analysis techniques to evaluate differences in cardiac function after 12 months of pacing in patients with pacing leads placed in different positions within the right ventricle (apically or septally).

Study Overview

• Status: Terminated
• Conditions: Heart Block; Ventricular Dysfunction; Atrioventricular Block; Sick Sinus Syndrome
• Intervention / Treatment: Other: Cardiac MRI with pacemaker stimulation; Other: Cardiac MRI with and without pacemaker stimulation

Detailed Description

Prolonged pacing from the right ventricular (RV) Apex has been shown to be associated with progressive left ventricular (LV) dysfunction. This has led to an interest in alternative right ventricular pacing sites. Only very few studies investigated the effect of alternative right ventricular pacing sites using three dimensional imaging. Using cardiac MRI volumetric left- and right ventricular analysis and three-dimensional reconstruction is more accurate compared to trans-thoracic echocardiogram. St. Jude Medical has developed a MRI conditional pacemaker system enabling for the first time to investigate alternative pacing sites using cardiac MRI.

Patients already implanted with an MRI conditional pacemaker system from St. Jude Medical will be enrolled in that study and subdivided into 4 groups (right ventricular pacing lead positioned apically or septally subdivided in patients paced for <50% of time or 50% or more). All patients will undergo cardiac MRI at enrollment and again 12 months later. Patients paced <50% of the time will undergo cardiac MRI with and without pacemaker stimulation at both visits.

• Study Type: Interventional
• Enrollment (Actual): 29
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Switzerland
  • Zurich, Switzerland, 8063
    • Stadtspital Triemli

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Have been implanted with an Accent MRI pacemaker and Tendril MRI leads.
• Have an RV lead implanted apically (group A) or septally (Group B)
• Are RV paced for <50% of the time (groups A2 and B2)
• Are RV paced for > 50% of the time (Groups A1 and B1)
• Are ≥ 18 years of age.
• Are able to provide written informed consent.
• Are willing and able to comply with the prescribed follow-up tests and schedule of evaluations.

Exclusion Criteria:

• Have permanent atrial fibrillation with preserved intrinsic conduction
• Have a non-MRI compatible device or material implant (e.g., intracranial aneurysm clip, non-MRI compatible devices or material, metals or alloys, etc.).
• Have a lead extender, plug or adaptor.
• Do not have an RV lead implanted apically or septally.
• Are eligible for groups A1 or B1 but appropriate group already has 20 patients enrolled.
• Are eligible for groups A2 or B2 but appropriate group already has 5 patients enrolled
• Are currently participating in another device or drug investigation which includes an active treatment arm.
• Are pregnant or planning to become pregnant during the duration of the study.
• Have a life expectancy of less than 12 months from Screening due to any life-threatening condition.
• Are contraindicated for an MRI scan due to any other reason.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

4

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Septal RV lead with >50% pacing (B1); Cardiac MRI with pacemaker stimulation	Other: Cardiac MRI with pacemaker stimulation; Patient is undergoing a Cardiac MRI at enrollment and 12 months later
Experimental: Septal RV lead with <50% pacing (B2); Cardiac MRI with and without pacemaker stimulation	Other: Cardiac MRI with and without pacemaker stimulation; Patient is undergoing a Cardiac MRI at enrollment and 12 months later
Experimental: Apical RV lead with >50% pacing (A1); Cardiac MRI with pacemaker stimulation	Other: Cardiac MRI with pacemaker stimulation; Patient is undergoing a Cardiac MRI at enrollment and 12 months later
Experimental: Apical RV lead with <50% pacing (A2); Cardiac MRI with and without pacemaker stimulation	Other: Cardiac MRI with and without pacemaker stimulation; Patient is undergoing a Cardiac MRI at enrollment and 12 months later

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Change in LV chamber volumes.	12 months (baseline to end of study)

Secondary Outcome Measures

Outcome Measure	Time Frame
Change in Dyssynchrony	12 months
Change in Ejection fraction	12 months
Change in Strain rate	12 months

Collaborators and Investigators

• Sponsor: Abbott Medical Devices
• Investigators: Principal Investigator: Rainer Zbinden, MD, Triemli Hospital

Study record dates

Study Major Dates

• Study Start: January 1, 2013
• Primary Completion (Actual): January 1, 2016
• Study Completion (Actual): January 1, 2016

Study Registration Dates

• First Submitted: February 21, 2013
• First Submitted That Met QC Criteria: February 21, 2013
• First Posted (Estimate): February 25, 2013

Study Record Updates

• Last Update Posted (Actual): July 24, 2020
• Last Update Submitted That Met QC Criteria: July 23, 2020
• Last Verified: July 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Heart Diseases; Cardiovascular Diseases; Arrhythmias, Cardiac; Cardiac Conduction System Disease; Arrhythmia, Sinus; Heart Block; Ventricular Dysfunction; Sick Sinus Syndrome; Atrioventricular Block
• Other Study ID Numbers: CR-12-048-CH-LV